CHF258.50
0.39%
SIX Swiss Exchange, Sep 29, 05:30 pm CEST. Closed.
ISIN
CH0582581713
Symbol
DESN

Dottikon ES Stock price

CHF258.50
-14.50 5.31% 1M
-78.00 23.18% 6M
-90.00 25.83% YTD
-40.00 13.40% 1Y
+43.50 20.23% 3Y
-45.50 14.97% 5Y
+219.63 564.95% 10Y
+234.60 981.59% 20Y
SIX Swiss Exchange, Closing price Tue, Sep 29 2026
-1.00 0.39%
Compare with Peer Group
ISIN
CH0582581713
Symbol
DESN
Industry

Is Dottikon ES a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
CHF3.6b
Enterprise Value
CHF3.5b
Net debt
positive
Cash
CHF200.0m
Shares outstanding
13.8m
Valuation (TTM | estimate)
P/E
34.6
P/S
8.4 | 6.7
EV/Sales
8.2 | 6.6
EV/FCF
119.8
P/B
3.3
Financial Health
Equity Ratio
77.9%
Return on Equity
9.5%
ROCE
9.2%
ROIC
9.1%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
CHF428.4m | CHF531.0m
EBITDA
CHF148.1m
EBIT
CHF116.8m
Net Income
CHF103.6m
Free Cash Flow
CHF29.3m
Growth (TTM | estimate)
Revenue
11.2% | 23.9%
EBITDA
5.4%
EBIT
-1.4%
Net Income
-1.9%
Free Cash Flow
193.3%
Margin
Gross
63.6%
EBITDA
34.6%
EBIT
27.3%
Net
24.2%
Free Cash Flow
6.8%
More
EPS
CHF7.5
FCF per Share
CHF2.1
Short interest
-
Employees
875
Rev per Employee
CHF490.0k

Dottikon ES Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Dottikon ES forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a Dottikon ES forecast:

Buy
75%
Hold
25%

Financial data from Dottikon ES

Mar '26
+/-
%
428 428
11% 11%
100%
- Direct Costs 156 156
24% 24%
36%
273 273
5% 5%
64%
- Selling and Administrative Expenses 103 103
7% 7%
24%
- Research and Development Expense - -
-
-
148 148
5% 5%
35%
- Depreciation and Amortization 31 31
42% 42%
7%
EBIT (Operating Income) EBIT 117 117
1% 1%
27%
Net Profit 104 104
2% 2%
24%

In millions CHF.

Don't miss a Thing! We will send you all news about Dottikon ES directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Dottikon ES Holding AG engages in the development and manufacture of chemicals, intermediates, and pharmaceutical ingredients. The company is headquartered in Dottikon, Aargau and currently employs 841 full-time employees. The company went IPO on 2005-03-31. Its product range includes active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, as well as industrial chemicals. Its pharmaceutical products can be found in medications for, among others, heart disease, asthma, high blood pressure and ulcers. Dottikon ES Holding AG's industrial end products include food additives, cosmetics, electro-chemicals, photo-chemicals and agricultural chemicals. The firm also offers distillation plants and thin layer evaporators for the recycling of solvents, as well as high temperature incinerators for the waste treatment of hazardous waste. As of March 31, 2012, the Company had two wholly owned subsidiaries: DOTTIKON EXCLUSIVE SYNTHESIS AG and DOTTIKON ES MANAGEMENT AG. The company also held a 33.9%-stake in SYSTAG, System Technik AG.

Head office Switzerland
CEO Dr. Blocher
Employees 875
Website dottikon.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today